longevity supplements

Al Jazeera reports that the booming longevity industry — anti-ageing treatments, supplements and clinics promising longer, healthier lives — is outpacing the scientific evidence behind many of its claims. The piece suggests consumers are spending on interventions whose long-term benefits and risks remain largely unproven, raising concerns about hype, regulation and safety as the market grows.

The FDA plans to highlight aging and longevity medicine in upcoming updates to the Federal Acquisition Regulation Supplement (FARS), according to a report by Genetic Engineering and Biotechnology News. The move signals growing regulatory attention to treatments targeting aging itself rather than individual age-related diseases, a field attracting increased investment and research interest.

Health outlets are examining the booming market for longevity supplements, with experts breaking down what the science actually says about whether products marketed for longer life deliver real benefits. The discussion comes amid growing consumer interest in anti-ageing pills and powders, and a push to separate evidence-backed options from marketing claims with little scientific support.

A new guide from Nutritional Outlook examines how supplement makers are formulating senolytic products—compounds intended to clear aged, dysfunctional cells linked to aging and chronic disease. The piece walks through current ingredient choices, dosing considerations, and the science behind cellular health claims, arriving as consumer interest in longevity-focused nutrition continues to grow and regulators scrutinize anti-aging claims.

Nutraceutical Business Review highlights recent scientific research on probiotics and healthy ageing, covering findings that link gut microbiome health to longevity and quality of life in older adults. The piece points to growing industry and consumer interest in probiotic supplements as part of ageing well, though it reports no specific new study or product launch.